Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News aTyr Pharma Inc ATYR

Healthcare Biotechnology
aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a biologic immunomodulator in clinical development for the treatment of interstitial lung disease (ILD), a group of immune-mediated disorders that can cause... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ATYR)

aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis

GlobeNewswire 8 days ago

aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update

GlobeNewswire November 7, 2024

aTyr Pharma to Present at Upcoming Investor Conferences

GlobeNewswire October 31, 2024

aTyr Pharma to Present at the LD Micro Main Event XVII in October

Newsfile October 14, 2024

aTyr Pharma's Lead Therapeutic Candidate Efzofitimod for Pulmonary Sarcoidosis to be Featured in Best of CHEST Journals at CHEST 2024 Annual Meeting

GlobeNewswire October 8, 2024

aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal

GlobeNewswire October 2, 2024

aTyr Pharma to Participate in September Investor Conferences

GlobeNewswire August 21, 2024

aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update 

GlobeNewswire August 13, 2024

aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations

GlobeNewswire August 6, 2024
View More News ››

Opinion & Analysis (NDAQ:ATYR)

Kyorin's $175M Partnership Offers Good Life for aTyr Pharma in Japan

Streetwise Reports January 7, 2020

Expedition Mining (V.EXU) poised to target $28 billion endoscopy equipment market

Richard (Rick) Mills July 27, 2015
View More Opinion ››

Bullboard Posts (NDAQ:ATYR)

LIFE - Monday Rundown, Tuesday Expectations

<< View Post To Watch Video >>
HDavis - September 13, 2021

Life Technologies Announces Fourth Quarter and Fis

Life Technologies Announces Fourth Quarter and Fiscal 2012 Results Fourth quarter revenue increased 3% to $999 million, or 4.5...
bc4u - February 4, 2013

Where are you Posters?...

I have been patiently waiting to see some other investors post something of value on this board...obviously to no avail. So I guess that...
fedora - May 9, 2001

There's something here

For months you guys have been ignoring this stock. I t has a captive market, i.e. the invalid and the aging and it's margins are...
fedora - April 17, 2001
View more Bullboard ››

Kootenay Silver Inc.

Kootenay Silver Inc.

Kootenay Silver Inc. is a Canada-based exploration company engaged in the discovery and development of mineral projects in ...
View More »